Laurus Labs Limited has informed the Exchange regarding a press release dated May 02, 2023, titled "Laurus Labs receives USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film (ODF) drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment".